Theralizumab

Product Specifications

CAS Number

906068-56-2

Target

Others|||Immunology/Inflammation related

Related Pathways

Others|||Immunology/Inflammation

Purity

0.9946

Bioactivity

Theralizumab (TGN1412) is an anti-CD28-targeting monoclonal antibody that directly stimulates T cells. Theralizumab has antitumor activity and is used for the treatment of B-cell chronic lymphocytic leukemia and rheumatoid arthritis.

Shipping Conditions

Cool pack

Storage Temperature

-20°C

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

NBP2-41249PCP 0.1 mL

Rabbit Polyclonal Arrestin 3 Antibody [PerCP]

Ask

View Details

037776-PE 200 µL

LILRA6, ID (LILRA6, ILT8, Leukocyte immunoglobulin-like receptor subfamily A member 6, Immunoglobulin-like transcript 8, Leukocyte Ig-like receptor) (PE)

Ask

View Details

HY-B0474R-01 25 mg

Tetracycline (hydrochloride) (Standard)

Ask

View Details

HY-B0474R-02 50 mg

Tetracycline (hydrochloride) (Standard)

Ask

View Details

HY-B0474R-03 100 mg

Tetracycline (hydrochloride) (Standard)

Ask

View Details

HY-B0474R-04 250 mg

Tetracycline (hydrochloride) (Standard)

Ask

View Details